chlormethiazole has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, AJ; Marshall, JW; Ridley, RM | 1 |
| Cross, AJ; Green, AR; Jones, JA; Murray, TK; Sydserff, SG | 1 |
2 other study(ies) available for chlormethiazole and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Body Temperature; Brain; Callithrix; Cerebral Arterial Diseases; Chlormethiazole; Female; Heart Rate; Ischemic Attack, Transient; Male; Motor Activity; Neuroprotective Agents; Rotation | 1999 |
Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations.
Topics: Animals; Arterial Occlusive Diseases; Chlormethiazole; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Ischemic Attack, Transient; Male; Neuroprotective Agents; Prosencephalon; Rats; Rats, Long-Evans | 2000 |